Biotech / Medical : Welcome to the POTP board, the DPP-IV company


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
From: rareearth4210/17/2006 9:45:15 PM
Read Replies (1) of 90
 
Here we are at just above a dollar a share.

Nothing has fundamentally changed with the company, the two phase 3 trials are recruiting, two phase 2 trials are also underway and it's likely this is another case of the market undervaluing a sparsely traded, poorly followed, microcap biotech.

I recently sold all of my AMLN because I think there's going to be a change in the slope of the Byetta uptake due to Januvia and Galvus and this will be perceived poorly by the market; I'm going to take some of those profits and double my POTP holdings at this level.

I still expect some sort of financing announcement before the end of the year.


RE42
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.